Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-039571

Chief Executive Officer acquired 320,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Barrow Robert · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Grant or award : show line 1 in the form +320,000 1,098,477 D
Loading xslF345X05/ownership.xml…